These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26796668)

  • 1. Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors.
    Guixà-González R; Javanainen M; Gómez-Soler M; Cordobilla B; Domingo JC; Sanz F; Pastor M; Ciruela F; Martinez-Seara H; Selent J
    Sci Rep; 2016 Jan; 6():19839. PubMed ID: 26796668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence.
    Pelassa S; Guidolin D; Venturini A; Averna M; Frumento G; Campanini L; Bernardi R; Cortelli P; Buonaura GC; Maura G; Agnati LF; Cervetto C; Marcoli M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.
    Beggiato S; Antonelli T; Tomasini MC; Borelli AC; Agnati LF; Tanganelli S; Fuxe K; Ferraro L
    Curr Protein Pept Sci; 2014; 15(7):673-80. PubMed ID: 25175458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.
    Fuxe K; Ferré S; Canals M; Torvinen M; Terasmaa A; Marcellino D; Goldberg SR; Staines W; Jacobsen KX; Lluis C; Woods AS; Agnati LF; Franco R
    J Mol Neurosci; 2005; 26(2-3):209-20. PubMed ID: 16012194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia.
    Borroto-Escuela DO; Ferraro L; Narvaez M; Tanganelli S; Beggiato S; Liu F; Rivera A; Fuxe K
    Cells; 2020 Apr; 9(5):. PubMed ID: 32349279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
    J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
    Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
    Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes.
    Cervetto C; Venturini A; Passalacqua M; Guidolin D; Genedani S; Fuxe K; Borroto-Esquela DO; Cortelli P; Woods A; Maura G; Marcoli M; Agnati LF
    J Neurochem; 2017 Jan; 140(2):268-279. PubMed ID: 27896809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
    Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
    Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.
    Navarro G; Carriba P; Gandía J; Ciruela F; Casadó V; Cortés A; Mallol J; Canela EI; Lluis C; Franco R
    ScientificWorldJournal; 2008 Oct; 8():1088-97. PubMed ID: 18956124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced level of docosahexaenoic acid shifts GPCR neuroreceptors to less ordered membrane regions.
    Javanainen M; Enkavi G; Guixà-Gonzaléz R; Kulig W; Martinez-Seara H; Levental I; Vattulainen I
    PLoS Comput Biol; 2019 May; 15(5):e1007033. PubMed ID: 31107861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.
    Casadó-Anguera V; Bonaventura J; Moreno E; Navarro G; Cortés A; Ferré S; Casadó V
    Biochem Soc Trans; 2016 Apr; 44(2):595-600. PubMed ID: 27068975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers.
    Genedani S; Guidolin D; Leo G; Filaferro M; Torvinen M; Woods AS; Fuxe K; Ferré S; Agnati LF
    J Mol Neurosci; 2005; 26(2-3):177-84. PubMed ID: 16012191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of dopamine receptor D2 and adenosine receptor A2A in human retinal pigment epithelium].
    Dong F; An JH; Ren YP; Yan DS; Zhou XT; Lü F; Hu DN; Chen JF; Qu J
    Zhonghua Yan Ke Za Zhi; 2007 Dec; 43(12):1110-3. PubMed ID: 18331682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.
    Borroto-Escuela DO; Flajolet M; Agnati LF; Greengard P; Fuxe K
    Methods Cell Biol; 2013; 117():141-64. PubMed ID: 24143976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of adenosine A
    Mizumura T; Kondo K; Kurita M; Kofuku Y; Natsume M; Imai S; Shiraishi Y; Ueda T; Shimada I
    Sci Adv; 2020 Mar; 6(12):eaay8544. PubMed ID: 32206717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors.
    Navarro G; Aymerich MS; Marcellino D; Cortés A; Casadó V; Mallol J; Canela EI; Agnati L; Woods AS; Fuxe K; Lluís C; Lanciego JL; Ferré S; Franco R
    J Biol Chem; 2009 Oct; 284(41):28058-28068. PubMed ID: 19632986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.